ISIS 3521/CGP64128A antisense inhibitor of protein kinase C data

At the Royal College of Physicians and Surgeons meeting in Vancouver, ISIP presented results from two Phase I studies in patients with a variety of cancers

Read the full 269 word article

How to gain access

Continue reading with a
two-week free trial.